Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONCT Oncternal Therapeutics, Inc.

盘前交易 07-23 05:31:41 EDT

0.5266

+0.0000

0.00%

最高0.5266	最低0.5266	成交量0.00
今开0.5266	昨收0.5266	日振幅0.00%
总市值155.85万	流通市值142.52万	总股本295.96万
成交额0.00	换手率0.00%	流通股本270.64万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONCT","market":"US","secType":"STK","nameCN":"Oncternal Therapeutics, Inc.","latestPrice":0.5266,"timestamp":1753214400000,"preClose":0.5266,"halted":0,"volume":0,"delay":0,"floatShares":2706360,"shares":2959645,"eps":-11.691605,"marketStatus":"盘前交易","change":0,"latestTime":"07-23 05:31:41 EDT","open":0.5266,"high":0.5266,"low":0.5266,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-11.691605,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753277400000},"marketStatusCode":1,"adr":0,"listingDate":1075784400000,"exchange":"NASDAQ","adjPreClose":0.5266,"volumeRatio":0,"impliedVol":2.3853,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ONCT","defaultTab":"news","newsList":[{"id":"2488778626","title":"Oncternal Therapeutics, Inc.盘中异动 早盘股价大跌8.34%报0.636美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488778626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488778626?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:34","pubTimestamp":1733150066,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时34分，Oncternal Therapeutics, Inc.股票出现异动，股价急速下挫8.34%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃，换手率分别为730.48%、693.12%、204.32%，振幅较大的相关个股有Senti Biosciences, Inc.、Cabaletta Bio, Inc.、Purple Biotech Ltd，振幅分别为49.54%、21.73%、20.27%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223426abf00237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223426abf00237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2487388563","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487388563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487388563?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:36","pubTimestamp":1732890992,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时36分，Oncternal Therapeutics, Inc.股票出现波动，股价急速跳水6.21%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Cabaletta Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Silo Pharma, Inc.、Tc Biopharm  Plc、Applied Therapeutics, Inc.较为活跃，换手率分别为147.46%、18.41%、10.55%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Cabaletta Bio, Inc.、Windtree Therapeutics, Inc.，振幅分别为29.85%、27.24%、22.96%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223632a25f7802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223632a25f7802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2486000476","title":"Oncternal Therapeutics, Inc.盘中异动 快速上涨5.11%报0.746美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486000476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486000476?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:43","pubTimestamp":1732632186,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时43分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅上涨5.11%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、木薯科学较为活跃，换手率分别为15.84%、12.74%、12.01%，振幅较大的相关个股有Citius Pharmaceuticals, Inc.、Fate Therapeutics, Inc.、Protagenic Therapeutics, Inc.，振幅分别为24.86%、21.90%、21.67%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224306971a8a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224306971a8a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2486903860","title":"Oncternal Therapeutics, Inc.股价重挫30.22% 市值跌71.14万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486903860","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486903860?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545179,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅跳水30.22%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Citius Pharmaceuticals, Inc.、Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为86.44%、59.99%、37.56%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223259a2548d27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223259a2548d27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2485623072","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485623072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485623072?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:43","pubTimestamp":1732286625,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时43分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅下跌5.17%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为897.54%、80.71%、68.93%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为44.82%、33.24%、30.69%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224345971a81b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224345971a81b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2485085127","title":"Oncternal Therapeutics, Inc.盘中异动 大幅上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485085127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485085127?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:55","pubTimestamp":1732132541,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时55分，Oncternal Therapeutics, Inc.股票出现波动，股价急速拉升5.56%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1888.00%、1336.15%、1015.27%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121035541abd2bb52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121035541abd2bb52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2484609184","title":"Oncternal Therapeutics, Inc.盘中异动 急速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484609184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484609184?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:08","pubTimestamp":1731949705,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时08分，Oncternal Therapeutics, Inc.股票出现异动，股价快速跳水5.26%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Hcw Biologics Inc.、Geovax Labs Inc C/Wts 29/09/2025、冠科美博涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃，换手率分别为1029.64%、564.36%、553.80%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为397.15%、129.51%、91.09%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119010825a2436e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119010825a2436e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2483822918","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌6.61%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483822918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483822918?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:02","pubTimestamp":1731510165,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时02分，Oncternal Therapeutics, Inc.股票出现波动，股价快速下跌6.61%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Kairos Pharma, Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为362.27%、217.64%、92.43%，振幅较大的相关个股有Lexeo Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kairos Pharma, Ltd.，振幅分别为44.21%、36.31%、28.72%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230245971a64f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230245971a64f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2481101087","title":"Oncternal Therapeutics, Inc.盘中异动 急速下跌5.11%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101087?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:36","pubTimestamp":1731076594,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时36分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅下跌5.11%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Fortrea Holdings Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为413.48%、21.72%、16.17%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822363598e417a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822363598e417a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2480943050","title":"Oncternal Therapeutics, Inc.盘中异动 快速跳水5.25%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480943050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480943050?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:40","pubTimestamp":1730400040,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时40分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅跳水5.25%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.32%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为273.02%、242.55%、196.92%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Vaccinex, Inc.、Promis Neurosciences Inc.，振幅分别为80.77%、47.15%、46.79%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101024040ab8ceb35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101024040ab8ceb35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2479238364","title":"Oncternal Therapeutics, Inc.盘中异动 大幅上涨5.23%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479238364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479238364?lang=zh_cn&edition=full","pubTime":"2024-10-29 23:28","pubTimestamp":1730215716,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日23时28分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅拉升5.23%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029232836ab7f63d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029232836ab7f63d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2477563168","title":"Oncternal Therapeutics, Inc.盘中异动 早盘大幅下跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477563168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477563168?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:41","pubTimestamp":1729777266,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时41分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅跳水5.52%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Dbv Technologies、Cns Pharmaceuticals, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为204.65%、107.56%、42.22%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Gt Biopharma, Inc.，振幅分别为45.75%、36.67%、17.80%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024214107ab70a7db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024214107ab70a7db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2477538025","title":"Oncternal Therapeutics, Inc.盘中异动 急速上涨5.73%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538025?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:37","pubTimestamp":1729690672,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时37分，Oncternal Therapeutics, Inc.股票出现异动，股价快速上涨5.73%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1068.71%、577.39%、289.30%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Virax Biolabs Group Limited，振幅分别为42.95%、31.68%、28.57%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213752971a1ce0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213752971a1ce0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2477337588","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌5.23%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477337588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477337588?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:30","pubTimestamp":1729603823,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时30分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅跳水5.23%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Tc Biopharm  Plc涨幅较大，Genprex, Inc.、Tc Biopharm  Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为1688.35%、1115.89%、1013.30%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Aptevo Therapeutics Inc.、Omega Therapeutics, Inc.，振幅分别为6.19%、6.07%、5.61%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221302498e3dc22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221302498e3dc22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2477559865","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨7.32%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477559865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477559865?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:31","pubTimestamp":1729517471,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时31分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅拉升7.32%。截至发稿，该股报1.54美元/股，成交量5434股，换手率0.18%，振幅0.00%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410212131119f53f82b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410212131119f53f82b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2475990255","title":"Oncternal Therapeutics, Inc.盘中异动 急速拉升7.44%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475990255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475990255?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:36","pubTimestamp":1729085772,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时36分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅上涨7.44%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213613a1e11ee2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213613a1e11ee2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2474205301","title":"Oncternal Therapeutics, Inc.盘中异动 下午盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474205301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474205301?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:15","pubTimestamp":1728501332,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时15分，Oncternal Therapeutics, Inc.股票出现异动，股价急速下挫5.32%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.、Can Fite Biopharma Ltd涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为727.56%、573.83%、250.22%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Inhibikase Therapeutics, Inc.，振幅分别为108.00%、73.66%、64.70%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003153298e3b865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003153298e3b865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2471386257","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨6.21%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471386257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471386257?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:53","pubTimestamp":1727704434,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时53分，Oncternal Therapeutics, Inc.股票出现波动，股价快速上涨6.21%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Kezar Life Sciences, Inc.、Prime Medicine, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Onconetix, Inc.较为活跃，换手率分别为61.66%、25.47%、24.49%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Plus Therapeutics, Inc.，振幅分别为34.02%、32.54%、28.10%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093021535598e39d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093021535598e39d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2470873810","title":"Oncternal Therapeutics, Inc.盘中异动 早盘快速上涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470873810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470873810?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:20","pubTimestamp":1727446851,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时20分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅拉升6.21%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092722205198e396af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092722205198e396af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2470878294","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470878294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470878294?lang=zh_cn&edition=full","pubTime":"2024-09-26 02:48","pubTimestamp":1727290098,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日02时48分，Oncternal Therapeutics, Inc.股票出现波动，股价急速跳水5.41%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926024819a1dc81a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926024819a1dc81a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oncternal.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.9285},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0582},{"period":"3month","weight":0.1745},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.1338},{"period":"ytd","weight":0.073}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oncternal Therapeutics, Inc.是一家特拉华州公司，于1997年9月24日注册成立。该公司是一家临床阶段的生物制药公司，专注于开发新型肿瘤疗法，用于治疗具有关键未满足医疗需求的癌症患者。Oncternal追求药物开发，靶向与癌症产生或进展有关的有希望但尚未开发的生物学途径，重点关注前列腺癌和血液系统恶性肿瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.060814},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.021415},{"month":3,"riseRate":0.318182,"avgChangeRate":-0.032008},{"month":4,"riseRate":0.318182,"avgChangeRate":-0.024914},{"month":5,"riseRate":0.5,"avgChangeRate":0.059467},{"month":6,"riseRate":0.409091,"avgChangeRate":0.010719},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.039595},{"month":8,"riseRate":0.47619,"avgChangeRate":-0.035974},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.045391},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.010874},{"month":11,"riseRate":0.47619,"avgChangeRate":0.007295},{"month":12,"riseRate":0.47619,"avgChangeRate":0.006683}],"exchange":"NASDAQ","name":"Oncternal Therapeutics, Inc.","nameEN":"Oncternal Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Oncternal Therapeutics, Inc.(ONCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Oncternal Therapeutics, Inc.,ONCT,Oncternal Therapeutics, Inc.股票,Oncternal Therapeutics, Inc.股票老虎,Oncternal Therapeutics, Inc.股票老虎国际,Oncternal Therapeutics, Inc.行情,Oncternal Therapeutics, Inc.股票行情,Oncternal Therapeutics, Inc.股价,Oncternal Therapeutics, Inc.股市,Oncternal Therapeutics, Inc.股票价格,Oncternal Therapeutics, Inc.股票交易,Oncternal Therapeutics, Inc.股票购买,Oncternal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Oncternal Therapeutics, Inc.(ONCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}